One Codex News Today

B-field implementation in Rust. Contribute to onecodex/rust-bfield development by creating an account on GitHub.

Laragen offers a range of services including Sanger sequencing, mouse genotyping, MiSeq sequencing, cell line and microbial identification, and fragment analysis.

One Codex and 4bases team up to empower clinicians with solutions for microbiome analysis

Invitae (NVTA) Q1 2021 Earnings Call Transcript Motley Fool Transcribing © The Motley Fool Logo of jester cap with thought bubble. Invitae (NYSE: NVTA) Laura DAngelo -- Head of Investor Relations Thank you, operator, and good afternoon, everyone. Thank you for joining us for our first-quarter 2021 results call. Joining us today are Sean George, our CEO; Shelly Guyer, our CFO; and Katherine Stueland, our chief commercial officer. As you listen to todays conference call, we e...

Share this article Share this article SAN FRANCISCO, May 4, 2021 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced financial and operating results for the first quarter ended March 31, 2021 signaling continued momentum into 2021. "We had a very strong start to the year, experiencing record daily volumes, and we expect that momentum to continue into the coming years," said Sean George, co-founder and chief executive officer of Invitae. "Genetic...

This story is available exclusively to Insider subscribers. Become an Insider and start reading now. 23andMe in February said its going public in a deal that values the company at $3.5 billion.  Despite 23andMes success, the consumer genomics market has largely bottomed out, an analyst said. Others hoping to cash in on genetic health assessments have pivoted or shuttered efforts altogether. As consumer genetics giant 23andMe prepares to go public, the person...

The company unveiled its inaugural ESG report. But the overall rise in growth stocks was its main catalyst.

expected to reach USD 1.72 billion by 2028 registering a CAGR of 15.02%, according to a new report by Grand View Research, Inc. Key drivers contributing to market expansion include the growing adoption of sequencing platforms for clinical diagnosis because of a significant reduction in the cost of installation. The easy availability of genomic and proteomic data is also expected to create lucrative growth opportunities in this market during the forecast period. Key suggestions from the report...

Transnetyx, One Codex Build Strategic Partnership to Provide a Complete Microbiome Analysis Service for Both Mice and Humans News provided by Share this article Share this article MEMPHIS, Tenn., Jan. 27, 2021 /PRNewswire/ -- Transnetyx, Inc. announced today its collaboration with One Codex on an end-to-end microbiome sequencing and analysis service. This offering will be driven by Transnetyxs wide-reaching global footprint in the model organism community and One Codexs deep expertise in the m...